{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-121685","form_type":"8-K","ticker":null,"cik":"0000786947","company_name":"ACURA PHARMACEUTICALS, INC","filed_at":"2026-11-03T13:20:04+00:00","discovered_at":"2026-11-03T13:25:00.918190+00:00","generated_at":"2026-11-03T13:25:48.373535+00:00","sec_items":["1.01","2.01","2.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.82,"calibrated_materiality_score":0.82,"confidence":"high","headline":"Acura Pharmaceuticals borrows $141,607 from AD Pharma; note balance hits $11.44M with going-concern warning","bullets":["Two new loans of $41,607 (Oct 19, 2026) and $100,000 (Oct 30, 2026) from Abuse Deterrent Pharma bring the secured note principal to $11,435,886.","Accrued interest is approximately $1,416,000 as of October 31, 2026; the note bears 5.25% interest, rising to 7.5% on overdue amounts.","Acura says without additional financing by late-November 2026 it must furlough or lay off employees, terminate operations, or seek bankruptcy protection.","AD Pharma agreement requires FDA acceptance of an NDA for LTX-03 by December 31, 2026, and payoff of the secured note by the same date.","Loan #66 of $100,000 on October 2, 2026 preceded the two disclosed loans; total aggregated principal rose from $2,319,279 in November 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-121685","json":"https://secwatch.observer/filing/0001104659-26-121685.json","markdown":"https://secwatch.observer/filing/0001104659-26-121685.md","text":"https://secwatch.observer/filing/0001104659-26-121685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/786947/000110465926121685/0001104659-26-121685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/786947/000110465926121685/tm2628790d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-03T13:25:48.373535+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}